Axsome Therapeutics, Inc. (AXSM) Social Stream
AXSOME THERAPEUTICS INC (AXSM) Price Targets From Analysts
Use the tables below to see what analysts covering AXSOME THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $180 | $34 | $98.272 | $69.8 | 40.79% |
| 2021-12-17 | 11 | $180 | $34 | $98.272 | $69.8 | 40.79% |
| 2021-12-20 | 11 | $180 | $26 | $95.727 | $69.8 | 37.14% |
| 2022-03-02 | 11 | $180 | $26 | $89.363 | $69.8 | 28.03% |
| 2022-03-07 | 11 | $180 | $31 | $88.454 | $69.8 | 26.72% |
| 2022-03-29 | 11 | $180 | $31 | $89.909 | $69.8 | 28.81% |
| 2022-04-21 | 11 | $180 | $34 | $90.454 | $69.8 | 29.59% |
| 2022-04-25 | 11 | $180 | $34 | $90.272 | $69.8 | 29.33% |
| 2022-04-27 | 11 | $180 | $27 | $88.181 | $69.8 | 26.33% |
| 2022-05-03 | 11 | $180 | $27 | $87.181 | $69.8 | 24.9% |
| 2022-06-02 | 10 | $180 | $27 | $84.1 | $69.8 | 20.49% |
| 2022-07-11 | 10 | $180 | $28 | $89.4 | $69.8 | 28.08% |
| 2022-08-10 | 10 | $180 | $28 | $89.5 | $69.8 | 28.22% |
| 2022-08-13 | 10 | $180 | $28 | $87.1 | $69.8 | 24.79% |
| 2022-08-21 | 10 | $180 | $34 | $90.6 | $69.8 | 29.8% |
| 2022-08-23 | 10 | $180 | $34 | $101.5 | $69.8 | 45.42% |
| 2022-09-02 | 10 | $210 | $34 | $106.5 | $69.8 | 52.58% |
| 2022-09-17 | 11 | $210 | $34 | $109.2 | $69.8 | 56.45% |
| 2022-10-04 | 11 | $210 | $34 | $108.1 | $69.8 | 54.87% |
| 2022-10-13 | 12 | $210 | $34 | $108.4 | $69.8 | 55.3% |
| 2022-10-24 | 12 | $210 | $35 | $104.272 | $69.8 | 49.39% |
| 2022-11-04 | 13 | $210 | $35 | $103.5 | $69.8 | 48.28% |
| 2022-11-08 | 13 | $210 | $35 | $103.416 | $69.8 | 48.16% |
| 2022-11-09 | 13 | $210 | $35 | $103.75 | $69.8 | 48.64% |
| 2022-11-18 | 13 | $210 | $34 | $105 | $69.8 | 50.43% |
| 2022-11-28 | 13 | $210 | $35 | $105.083 | $69.8 | 50.55% |
| 2022-11-29 | 13 | $210 | $52 | $109.916 | $69.8 | 57.47% |
| 2023-01-03 | 14 | $210 | $52 | $109 | $69.8 | 56.16% |
| 2023-01-26 | 15 | $210 | $52 | $106.571 | $69.8 | 52.68% |
| 2023-02-14 | 15 | $210 | $52 | $107 | $69.8 | 53.3% |
| 2023-02-28 | 15 | $210 | $52 | $107.357 | $69.8 | 53.81% |
| 2023-03-13 | 15 | $210 | $52 | $107.857 | $69.8 | 54.52% |
| 2023-03-20 | 15 | $200 | $52 | $107.142 | $69.8 | 53.5% |
| 2023-04-05 | 15 | $200 | $52 | $106.785 | $69.8 | 52.99% |
| 2023-04-17 | 15 | $200 | $52 | $106.642 | $69.8 | 52.78% |
| 2023-04-27 | 15 | $200 | $52 | $105.2 | $69.8 | 50.72% |
| 2023-05-09 | 15 | $200 | $57 | $105.533 | $69.8 | 51.19% |
| 2023-05-10 | 15 | $200 | $57 | $107.5 | $69.8 | 54.01% |
| 2023-05-23 | 15 | $200 | $57 | $109 | $69.8 | 56.16% |
The Trend in the Analyst Price Target
Over the past 14 months, AXSM's average price target has gone up $19.09.
Over the past 51 weeks, AXSM's average upside potential has been 84.11%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-02 | 10 | 180 | 27 | 86.636 | 24.78 | 249.62% |
| 2022-09-10 | 11 | 210 | 34 | 109.200 | 62.07 | 75.93% |
| 2022-11-07 | 13 | 210 | 35 | 103.416 | 56.82 | 82.01% |
| 2022-11-08 | 13 | 210 | 35 | 103.416 | 63.46 | 62.96% |
| 2023-04-27 | 15 | 200 | 52 | 105.200 | 71.16 | 47.84% |
AXSM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.47 | 12 | 0 | 2 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
Over the past 26 weeks, AXSM's average broker recommendation rating worsened by 0.09.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how AXSOME THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4232.07% of that group.
- AXSM has a higher number of analysts covering the stock than 3894.65% of stocks in the mid market cap category.
- AXSOME THERAPEUTICS INC's average analyst price target is higher than 3853.81% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AXSOME THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1188.05% of them.
Stocks similar to AXSOME THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPMC, MCRB, and ASND.
View All Top Stocks by Price Target
Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!